FDA approves Onsolis for cancer patients FDA rejects Watson prostate cancer drug FDA to require label changes for immunosuppressant drugs FDA agrees to review Victory Pharma's MGX006 NDA OSI Pharmaceuticals, Genentech announce results of Tarceva trial J&J completes acquisition of Cougar Biotechnology Sciele Pharma terminates agreement to acquire Victory Pharma OSI Pharmaceuticals moving to Westchester Co., N.Y. Merck, Portola to collaborate to develop stroke treatment Rexahn Pharmaceuticals regains compliance with NYSE First Previous 234 235 236 237 238 Next Last